Skip to main content
placeholder image

Fasting target for hyperglycaemia in pregnancy

Journal Article


Abstract


  • Knowledge of the fasting plasma glucose of healthy women may assist in the setting of treatment targets for women with

    hyperglycaemia in pregnancy (HIP). This study examines the pregnancy glucose tolerance test results of 3344 women

    without HIP collected over a three-year period. The median fasting plasma glucose was 4.4 mmol/L with an interquartile

    range of 4.2–4.6 mmol/L and a 5th to 95th centile of 3.8–4.9 mmol/L. As the diagnostic fasting glucose level for HIP is

    ≥5.1 mmol/L, these data support a treatment target of ≤5.0 mmol/L.

Publication Date


  • 2016

Citation


  • Moses, R. G., Wong, V. C. K., Lambert, K. & Morris, G. J. (2016). Fasting target for hyperglycaemia in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 56 530-531.

Scopus Eid


  • 2-s2.0-84991089181

Number Of Pages


  • 1

Start Page


  • 530

End Page


  • 531

Volume


  • 56

Place Of Publication


  • Australia

Abstract


  • Knowledge of the fasting plasma glucose of healthy women may assist in the setting of treatment targets for women with

    hyperglycaemia in pregnancy (HIP). This study examines the pregnancy glucose tolerance test results of 3344 women

    without HIP collected over a three-year period. The median fasting plasma glucose was 4.4 mmol/L with an interquartile

    range of 4.2–4.6 mmol/L and a 5th to 95th centile of 3.8–4.9 mmol/L. As the diagnostic fasting glucose level for HIP is

    ≥5.1 mmol/L, these data support a treatment target of ≤5.0 mmol/L.

Publication Date


  • 2016

Citation


  • Moses, R. G., Wong, V. C. K., Lambert, K. & Morris, G. J. (2016). Fasting target for hyperglycaemia in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 56 530-531.

Scopus Eid


  • 2-s2.0-84991089181

Number Of Pages


  • 1

Start Page


  • 530

End Page


  • 531

Volume


  • 56

Place Of Publication


  • Australia